Reports on the ability of the antibody C-20, which was derived from the breast cancer gene designated as BRCA1, to recognize smooth muscle cells. Results of immunohistochemical staining of C-20; Cross-reaction of C-20 with some tyrosine kinase receptors; Antibodies that can be used as differentiation markers of smooth muscle cells.